Insights

Expanding R&D Collaborations Spark Therapeutics actively partners with academic institutions and biotech companies, such as Tulane University and Neurochase Limited, indicating ongoing opportunities for collaboration tools, research support services, and joint development projects in gene therapy and rare diseases.

Growing Market Focus With a diverse pipeline addressing inherited retinal diseases, neurodegenerative disorders, and liver-targeted conditions like hemophilia, Spark presents sales opportunities across a broad range of biotech and healthcare sectors seeking innovative gene therapy solutions.

Recent Workforce Reduction The company's decision to cut over half its Philadelphia workforce suggests a strategic realignment, which may open avenues for specialized consulting, talent acquisition solutions, or contract research services to support restructuring efforts.

Financial Positioning With revenues between 100 million and 250 million dollars and funding of 37 million dollars, Spark is in a growth phase that may require advanced data analytics, cloud services, and biotech infrastructure support to accelerate R&D productivity.

Technology Stack and Data Needs Utilizing a sophisticated tech stack including cloud services, NoSQL databases, and machine learning tools like scikit-learn, Spark is likely seeking innovative IT solutions, hardware, and software that enhance data management and clinical research capabilities.

Spark Therapeutics, Inc. Tech Stack

Spark Therapeutics, Inc. uses 8 technology products and services including Cloudflare, Salesforce, NoSQL, and more. Explore Spark Therapeutics, Inc.'s tech stack below.

  • Cloudflare
    Content Management System
  • Salesforce
    Customer Relationship Management
  • NoSQL
    Database
  • Alpine.js
    Javascript Frameworks
  • scikit-learn
    Machine Learning
  • Microsoft Word
    Office Suites
  • Windows Server 2012
    Operating Systems
  • GraphQL
    Programming Languages

Media & News

Spark Therapeutics, Inc.'s Email Address Formats

Spark Therapeutics, Inc. uses at least 1 format(s):
Spark Therapeutics, Inc. Email FormatsExamplePercentage
First.Last@sparktx.comJohn.Doe@sparktx.com
92%
FLast@sparktx.comJDoe@sparktx.com
6%
First.Middle@sparktx.comJohn.Michael@sparktx.com
1%
LastFir@sparktx.comDoeJoh@sparktx.com
1%

Frequently Asked Questions

Where is Spark Therapeutics, Inc.'s headquarters located?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc.'s main headquarters is located at 3737 Market Street Suite 1300 Philadelphia, Pennsylvania 19104 United States. The company has employees across 6 continents, including North AmericaEuropeAfrica.

What is Spark Therapeutics, Inc.'s phone number?

Minus sign iconPlus sign icon
You can contact Spark Therapeutics, Inc.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Spark Therapeutics, Inc.'s stock symbol?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc. is a publicly traded company; the company's stock symbol is ONCE.

What is Spark Therapeutics, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc.'s official website is sparktx.com and has social profiles on LinkedIn.

What is Spark Therapeutics, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Spark Therapeutics, Inc. have currently?

Minus sign iconPlus sign icon
As of February 2026, Spark Therapeutics, Inc. has approximately 335 employees across 6 continents, including North AmericaEuropeAfrica. Key team members include Chief Strategy Officer (cso) And Chief Financial Officer (cfo): M. R.Chief Human Resources Officer: S. A. K.Vp Head Of Systemic And Ocular Research: V. H.. Explore Spark Therapeutics, Inc.'s employee directory with LeadIQ.

What industry does Spark Therapeutics, Inc. belong to?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc. operates in the Biotechnology Research industry.

What technology does Spark Therapeutics, Inc. use?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc.'s tech stack includes CloudflareSalesforceNoSQLAlpine.jsscikit-learnMicrosoft WordWindows Server 2012GraphQL.

What is Spark Therapeutics, Inc.'s email format?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc.'s email format typically follows the pattern of First.Last@sparktx.com. Find more Spark Therapeutics, Inc. email formats with LeadIQ.

How much funding has Spark Therapeutics, Inc. raised to date?

Minus sign iconPlus sign icon
As of February 2026, Spark Therapeutics, Inc. has raised $37M in funding. The last funding round occurred on Jan 01, 2013 for $35M.

When was Spark Therapeutics, Inc. founded?

Minus sign iconPlus sign icon
Spark Therapeutics, Inc. was founded in 2013.

Spark Therapeutics, Inc.

Biotechnology ResearchPennsylvania, United States201-500 Employees

At Spark® Therapeutics, we believe in a world where no life is limited by disease. 

We were born of innovation, springing from the curiosity, imagination and dedication of remarkable scientists and healthcare visionaries. Our mission is to unlock the power of gene therapy to accelerate healthcare transformation.  
 
Since our founding, we have been committed to bringing a wide range of expertise to build a fully integrated gene therapy company focused on inherited retinal diseases (IRDs), neurodegenerative diseases, as well as diseases that can be addressed by targeting the liver, such as hemophilia. We are seeking talented individuals with diverse experiences, abilities and interests who have the curiosity, courage and drive to reimagine a new health care paradigm.  
 
Join us on a journey through uncharted territory – seeking to bring gene therapy to people worldwide. The resilience of the people we serve is our inspiration to break barriers, as we strive to turn genes into medicine. Spark® is a member of the Roche Group.  
 
Know that working at Spark Therapeutics is not just another job; it is a once-in-a-lifetime opportunity. We embrace the challenges before us and the uncertainty inherent in them. Ultimately, we are working to create a world where no life is limited by disease. To learn more about Spark and our open positions, visit www.sparktx.com. You can also find us on Twitter at @Spark_tx. 

Spark’s social media sites are monitored from Monday to Friday during normal business hours. Questions or concerns should be directed here: https://sparktx.com/contact-us/.

Section iconCompany Overview

Headquarters
3737 Market Street Suite 1300 Philadelphia, Pennsylvania 19104 United States
Phone number
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
ONCE
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
201-500

Section iconFunding & Financials

  • $37M

    Spark Therapeutics, Inc. has raised a total of $37M of funding over 2 rounds. Their latest funding round was raised on Jan 01, 2013 in the amount of $35Mas a investment.

  • $100M$250M

    Spark Therapeutics, Inc.'s revenue is estimated to be in the range of $100M$250M

Section iconFunding & Financials

  • $37M

    Spark Therapeutics, Inc. has raised a total of $37M of funding over 2 rounds. Their latest funding round was raised on Jan 01, 2013 in the amount of $35Mas a investment.

  • $100M$250M

    Spark Therapeutics, Inc.'s revenue is estimated to be in the range of $100M$250M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.